From: New low-dose liquid pilocarpine formulation for treating dry mouth in Sjögren’s syndrome: clinical efficacy, symptom relief, and improvement in quality of life
Time (day)
Pilocarpine concentration (μg/mL) a
Residual (%)
0
0.56 ± 0.03
100
3
0.52 ± 0.02
92.8
7
0.59 ± 0.01
105.3
14
0.55 ± 0.02
98.4
28
0.55 ± 0.01
98.6